[
    [
        {
            "time": "2018-03-15",
            "original_text": "J&J CEO Gorsky spurns U.S. congressional hearing on carcinogens in talc products",
            "features": {
                "keywords": [
                    "J&J",
                    "CEO",
                    "Gorsky",
                    "spurns",
                    "congressional",
                    "hearing",
                    "carcinogens",
                    "talc"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-04-10",
            "original_text": "Johnson & Johnson Emerging Out Of A Dark Place",
            "features": {
                "keywords": [
                    "Johnson",
                    "&",
                    "Johnson",
                    "Emerging",
                    "Dark",
                    "Place"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-05-20",
            "original_text": "Amgen Gets FDA Approval for J&J/Merck's Remicade Biosimilar",
            "features": {
                "keywords": [
                    "Amgen",
                    "FDA",
                    "Approval",
                    "J&J",
                    "Merck",
                    "Remicade",
                    "Biosimilar"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-12-09",
            "original_text": "J&J Presents Data on CAR-T Therapy Drug and Imbruvica at ASH",
            "features": {
                "keywords": [
                    "J&J",
                    "Presents",
                    "Data",
                    "CAR-T",
                    "Therapy",
                    "Drug",
                    "Imbruvica",
                    "ASH"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-11-25",
            "original_text": "Bluebird Bio Stock Is Rising on Promising Cancer-Drug Data",
            "features": {
                "keywords": [
                    "Bluebird",
                    "Bio",
                    "Stock",
                    "Rising",
                    "Promising",
                    "Cancer-Drug",
                    "Data"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 9,
                "Importance": 6,
                "Impact": 5,
                "Duration": 3,
                "Entity_Density": 6,
                "Market_Scope": 2,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]